BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22260698)

  • 1. Targeting phosphoinositide 3-kinase δ for allergic asthma.
    Rowan WC; Smith JL; Affleck K; Amour A
    Biochem Soc Trans; 2012 Feb; 40(1):240-5. PubMed ID: 22260698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases.
    Sriskantharajah S; Hamblin N; Worsley S; Calver AR; Hessel EM; Amour A
    Ann N Y Acad Sci; 2013 Mar; 1280():35-9. PubMed ID: 23551101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation.
    Takeda M; Ito W; Tanabe M; Ueki S; Kihara J; Kato H; Tanigai T; Kayaba H; Sasaki T; Chihara J
    Int Arch Allergy Immunol; 2010; 152 Suppl 1():90-5. PubMed ID: 20523070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function.
    Fung-Leung WP
    Cell Signal; 2011 Apr; 23(4):603-8. PubMed ID: 20940048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation.
    Haylock-Jacobs S; Comerford I; Bunting M; Kara E; Townley S; Klingler-Hoffmann M; Vanhaesebroeck B; Puri KD; McColl SR
    J Autoimmun; 2011 May; 36(3-4):278-87. PubMed ID: 21396797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of the tyrosine kinase signaling cascade for asthma.
    Wong WS
    Curr Opin Pharmacol; 2005 Jun; 5(3):264-71. PubMed ID: 15907913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells and asthma.
    Robinson DS
    Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma.
    Park SJ; Min KH; Lee YC
    Respirology; 2008 Nov; 13(6):764-71. PubMed ID: 18811876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.
    Lee KS; Lee HK; Hayflick JS; Lee YC; Puri KD
    FASEB J; 2006 Mar; 20(3):455-65. PubMed ID: 16507763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients.
    Southworth T; Plumb J; Gupta V; Pearson J; Ramis I; Lehner MD; Miralpeix M; Singh D
    Respir Res; 2016 Oct; 17(1):124. PubMed ID: 27716212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma.
    Lee KS; Park SJ; Kim SR; Min KH; Jin SM; Puri KD; Lee YC
    J Allergy Clin Immunol; 2006 Aug; 118(2):403-9. PubMed ID: 16890765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective PI3Kδ inhibitors, a review of the patent literature.
    Norman P
    Expert Opin Ther Pat; 2011 Nov; 21(11):1773-90. PubMed ID: 22017414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms in allergic airway inflammation - lessons from studies in the mouse.
    Shum BO; Rolph MS; Sewell WA
    Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
    Barnes PJ
    Clin Exp Allergy; 2009 Aug; 39(8):1145-51. PubMed ID: 19538350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia.
    Chialda L; Zhang M; Brune K; Pahl A
    Respir Res; 2005 Apr; 6(1):36. PubMed ID: 15833106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
    Ito K; Caramori G; Adcock IM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
    Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
    J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a natural PI3Kδ inhibitor through virtual screening and biological assay study.
    Guo JF; Ning ZQ; Wu X; Qiao YJ; Wang X
    Biochem Biophys Res Commun; 2019 Jan; 508(3):709-714. PubMed ID: 30528237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 immunity in patients with allergic asthma.
    Zhao Y; Yang J; Gao YD; Guo W
    Int Arch Allergy Immunol; 2010; 151(4):297-307. PubMed ID: 19844129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.